American Osteopathic Association (AOA) - Comment
|
This is a Comment on the Food and Drug Administration (FDA) Notice: Using Innovative Technologies and Other Conditions of Safe Use to Expand Drug Products Considered Nonprescription
For related information,
Open Docket Folder
Comment
N/A
No documents available.
Attachments( 1 ) |
|
Comment Period Closed
May 7 2012, at 11:59 PM ET
ID:
FDA-2012-N-0171-0112
Tracking Number:
81024fc2
Submitter Information
Country:
United States
State or Province:
DC
Category:
Association - D0003
|
